美国结核病靶向疫苗接种策略的模型研究
研究利用确定性房室传播模型模拟美国结核分枝杆菌感染与发病,校准2024年监测数据,评估针对高风险人群接种新疫苗的效益。乐观情景下接种所有高风险组每年可预防5385例(减少51.8%),保守情景下预防1348例(减少13.0%);包含非美国出生者和HIV感染者的策略最有效。
要点
- 靶向接种HIV感染者、非美国出生者和有医学合并症者等高风险成人可大幅降低结核病发病率。
- 乐观情景下每年预防5385例(减少51.8%),保守情景下预防1348例(减少13.0%)。
- 包含非美国出生者和HIV感染者的接种策略效率最高、影响最大。
核心结论
- 对从结核分枝杆菌感染进展为结核病高风险的成人进行靶向疫苗接种,可大幅降低美国结核病发病率。
- 包含非美国出生者和HIV感染者的策略最有效且效率最高。
研究设计与样本
- 确定性房室传播模型,模拟美国结核分枝杆菌感染、传播和进展为结核病,按四个风险组分层。
- 模型校准至2024年美国结核病监测数据,评估乐观和保守情景下疫苗效力、保护时长和接种覆盖率变化的影响。
主要发现
- 乐观情景下接种所有高风险组(HIV感染者、非美国出生者、有医学合并症者)每年预防5385例,减少51.8%(95% UI: 35.2-66.8),NNV=366。
- 保守情景下同一策略每年预防1348例,减少13.0%(95% UI: 6.4-19.8),NNV=510。
- 策略排名在所有敏感性和不确定性分析中保持不变。
关键数值与推荐
- 乐观情景:接种所有高风险组每年预防5385例(51.8%减少,95% UI: 35.2-66.8),NNV=366。
- 保守情景:接种所有高风险组每年预防1348例(13.0%减少,95% UI: 6.4-19.8),NNV=510。
临床怎么用
- 优先考虑包含非美国出生者和HIV感染者的靶向接种策略,以最大化健康影响和效率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tuberculosis (TB) incidence in the United States has remained elevated above pre-pandemic levels since 2021, with over 85% of cases resulting from reactivation of Mycobacterium tuberculosis (Mtb) infection. New vaccines that would prevent TB in adults are under development, but the potential health impact of a program prioritizing non-U.S.-born persons and persons with medical comorbidities, including persons living with HIV (PLWH), has not been evaluated. METHODS: We developed a deterministic compartmental transmission model that simulates Mtb infection, transmission, and progression to TB in the U.S., stratified into four risk groups. We calibrated the model to 2024 U.S. TB surveillance data and estimated annual cases prevented, percent reduction in TB cases, and number needed to vaccinate (NNV) for targeted vaccination strategies under optimistic and conservative scenarios, varying vaccine efficacy, duration of protection, and vaccination coverage. RESULTS: Under an optimistic scenario, vaccinating all high-risk groups (PLWH, non-U.S.-born persons, and persons with medical comorbidities) prevented 5385 cases per year (51.8% reduction, 95% UI: 35.2-66.8, NNV = 366). Under a conservative scenario, the same strategy prevented 1348 cases per year (13.0% reduction, 95% UI: 6.4-19.8, NNV = 510). Strategy rankings were preserved across all sensitivity and uncertainty analyses. CONCLUSIONS: Targeted vaccination of adults at high risk of progression from Mtb infection to TB disease can reduce U.S. TB incidence substantially. Strategies that include non-U.S.-born persons and PLWH are most efficient and impactful.
引用
- Rothman JE, Castro KG, Lopman BA, et al. Targeted tuberculosis vaccination strategies in the United States: A modeling study. Vaccine. 2026. PMID: 42771941. doi:10.1016/j.vaccine.2026.129174
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。